Featuring a discussion on recent clinical trial data on the use
of CAR T-cell therapy in the management of non-Hodgkin lymphoma
with Dr Tanya Siddiqi, including the following topics:
CAR T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma — Tanya
Siddiqi, MD (00:00)
Case: A man in his late 50s with recurrent DLBCL attains
complete remission after receiving axicabtagene ciloleucel on the
Phase I/II ZUMA-1 trial (32:19)
Case: A woman in her mid-60s with relapsed/refractory DLBCL
receives lisocabtagene maraleucel on the Phase I TRANSCEND NHL 001
study (36:07)
Case: A man in his late 60s with multiple regimen-relapsed CLL
receives lisocabtagene maraleucel on the Phase I/II TRANSCEND CLL
004 study (38:34)
Tumor lysis syndrome in patients receiving CAR T-cell therapy;
FDA regenerative medicine advanced therapy designation for
tisagenlecleucel in relapsed/refractory follicular lymphoma
(43:08)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.